Metabolic functions of AMPK: Aspects of structure and of natural mutations in the regulatory gamma subunits
β Scribed by Cynthia Moffat; Mary Ellen Harper
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 218 KB
- Volume
- 62
- Category
- Article
- ISSN
- 1521-6543
- DOI
- 10.1002/iub.387
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
AMPβactivated protein kinase, AMPK, is widely accepted as the master regulator of energy levels within the cell. Responding quickly to changing energy demands, AMPK works to restore levels of ATP during times of cellular stress by promoting ATP producing catabolic pathways and inhibiting ATP consuming anabolic ones. As a heterotrimeric protein complex, AMPK's subunits each act in unique and crucial ways to control AMPK function and its localization within the cell. Research in the last decade has identified and begun to characterize the impact of naturally occurring mutations in the gamma regulatory subunits. Mutations in the Ξ³2 subunit have implications for cardiac function and disease, while the R225W mutation in the Ξ³3 subunit have implications for skeletal muscle fuel metabolism and resistance to fatigue. Research focused on structureβfunction aspects of AMPK regulatory subunits will lead to a better understanding of the roles of AMPK in health and disease. Β© 2010 IUBMB IUBMB Life, 62(10): 739β745, 2010
π SIMILAR VOLUMES
Neurospora crassa possesses a set of nitrogenregulated enzymes whose expression requires a lifting of nitrogen catabolite repression and specific induction. The nit-2 gene is a major regulatory locus which appears to act in a positive way to turn on the expression of these nitrogen-related enzymes w
In this contribution we describe the changes in structure and functioning of the photosynthetic apparatus of the unicellular green alga Scenedesmus obliquus induced by inhibition or induction of polyamine biosynthesis. The synthesis or inhibition is controlled by white light of low and high intensit
Mucolipidosis type III (MLIII) is an autosomal recessive disorder affecting lysosomal hydrolase trafficking. In a study of 10 patients from seven families with a clinical phenotype and enzymatic diagnosis of MLIII, six novel GNPTG gene mutations were identified. These included missense (p.T286M) and
PRKAR1A encodes the regulatory subunit type 1-alpha (RIalpha) of the cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA). Inactivating PRKAR1A mutations are known to be responsible for the multiple neoplasia and lentiginosis syndrome Carney complex (CNC). To date, at least 117 patho